Low serum adiponectin level is predictor of arterial stiffness in new onset diabetes after renal transplantation


Background: The purpose of this study was to determine whether the level of adiponectin in serum of renal transplant patients is associated with arterial stiffness related to new onset diabetes after transplantation (NODAT). Methods: A total of 90 previously non-diabetic patients who underwent renal transplantation between 1999 and 2009 were enrolled. We evaluated their diabetic risk factors, lipid profiles, brachial-ankle pulse wave velocity (baPWV), ankle-brachial blood pressure index (ABPI) and serum adiponectin level before and after transplantation. Results: Eleven (12.2%) patients were diagnosed with NODAT and 79 (87.8%) without (non-NO-DAT). The mean post-transplant serum adiponectin level in NODAT patients was significantly lower than that in non-NODAT patients (11.9 vs. 16.4 μg/ml, p = 0.01), whereas the mean baPWV level in NODAT patients was significantly higher (1686 vs. 1468 cm/s, p = 0.016). We found a significant inverse correlation between mean pre-transplant serum adiponectin and baPWV level (r = -0.27, p = 0.011). Furthermore, patients with lower pretransplant serum adiponectin levels (<20 μg/ml) developed NODAT significantly more frequently than those with higher levels (p = 0.038) and the mean baPWV level in the former was also significantly higher (1520 vs. 1412 cm/s, p = 0.047). Conclusion: Our results indicate that low pre-transplant serum adiponectin level is associated with arterial stiffness in development of NODAT in patients who undergo renal transplantation.

Share and Cite:

Nishimura, K. , Hirai, T. , Nakazawa, S. , Yamanaka, K. , Kishikawa, H. and Ichikawa, Y. (2012) Low serum adiponectin level is predictor of arterial stiffness in new onset diabetes after renal transplantation. Journal of Diabetes Mellitus, 2, 327-331. doi: 10.4236/jdm.2012.23051.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Pavlakis, M. (2005) New-onset diabetes after transplantation. CurrDiab Rep, 5, 300-304. doi:10.1007/s11892-005-0027-y
[2] OpazoSaez, A., Kos, M., Witzke, O., Kribben, A. and Nurn-berger, J. (2008) Effect of new-onset diabetes mellitus on arterial stiffness in renal transplantation. Transplant International, 21, 930-935. doi:10.1111/j.1432-2277.2008.00702.x
[3] Li, S., Shin, H.J., Ding, E.L. and van Dam, R.M. (2009) Adiponectin levels and risk of type 2 diabetes: A systematic review and meta-analysis. The Journal of the American Medical Association, 302, 179-188. doi:10.1001/jama.2009.976
[4] Bayés, B., Granada, M.L., Pastor, M.C., Lauzurica, R., Salinas, I., Sanmarti, A., Espinal, A., Navarro, M., Bonal, J. and Romero, R. (2007) Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. American Journal of Transplantation, 7, 416-422. doi:10.1111/j.1600-6143.2006.01646.x
[5] Wie?ek, A., Adamczak, M. and Chudek, J. (2007) Adiponectin—An adipokine with unique metabolic properties. Journal: Nephrol Dial Transplant, 22, 981-988. doi:10.1093/ndt/gfl814
[6] Nishimura, K., Kishikawa, H., Kato, T., Kobayashi, Y., Fujii, N., Takahara, S. and Ichikawa, Y. (2009) Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: Single-center cross-sectional analysis. Transplant International, 22, 694-701. doi:10.1111/j.1432-2277.2009.00849.x
[7] Hirai, T., Okuno, A., Souda, T., Yonemoto, S., Yamanaka, K., Fujii, N., Kishikawa, H., Nishimura, K. and Ichikawa Y. (2010) Evaluation of arterial stiffness after successful renal transplantation using brachial-ankle pulse wave velocity. Transplantation Proceedings, 42, 4061-4063. doi:10.1016/j.transproceed.2010.09.083
[8] Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. and Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419. doi:10.1007/BF00280883
[9] Mahmud, A. and Freely, J. (2005) Adiponectin and arterial stiffness. American Journal of Hypertension, 18, 1543-1548. doi:10.1016/j.amjhyper.2005.06.014
[10] Kato, K., Matsuhisa, M., Ichimaru, N., Takahara, S., Kojima, Y., Yamamoto, K., Shiraiwa, T., Kuroda, A., Katakami, N., Sakamoto, K., Matsuoka, T.A., Kaneto, H., Yamasaki, Y. and Hori M. (2008) The impact of new-onset diabetes on arterial stiffness after renal transplantation. Endocrine Journal, 55, 677-683. doi:10.1507/endocrj.K07E-138
[11] Nishioka, T., Akiyama, T., Nose, K. and Koike, H. (2008) Arterial stiffness after successful renal transplantation. Transplantation Proceedings, 40, 2405-2408. doi:10.1016/j.transproceed.2008.07.038
[12] Strozecki, P., Adamowicz, A., Kozlowski, M., Wlodarczyk, Z. and Manitius, J. (2011) Progressive arterial stiffening in kidney transplant recipients. Annals of Transplantation, 30, 30-35.
[13] Ha, C.Y., Kim, J.Y., Paik, J.K., Kim, O.Y., Paik, Y.H., Lee, E.J. and Lee, J.H. (2011) The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 Diabetes. Clinical Endocrinology, 2011. doi:10.1111/j.1365-2265.2011.04244.x
[14] Van Laecke, S., Maréchal, C., Verbeke, F., Peeters, P., Van Biesen, W., Devuyst, O. and Vanholder, R. (2011) The relation between hypomagnesaemia and vascular stiffness in renal transplant recipients. Nephrology Dialysis Transplantation, 26, 2362-2369. doi:10.1093/ndt/gfq728
[15] Gungor, O., Kircelli, F., Demirci, M.S., Tuncel, P., Sisman, A.R., Tatar, E., Hur, E., Asci, G., Ok, E. and Toz, H. (2011) Serum paraoxonase 1 activity predicts arterial stiffness in renal transplant recipients. Journal of Atherosclerosis and Thrombosis, 18, 901-905. doi:10.5551/jat.9175
[16] Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S., Sakai, N., Nakajima, T., Hasegawa, K., Murakami, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Hanafusa, T. and Matsuzawa, Y. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 1595-1599. doi:10.1161/01.ATV.20.6.1595
[17] Provan, S.A., Angel, K., Semb, A.G., Mowinckel, P., Agewall, S., Atar, D. and Kvien, T.K. (2011) Early prediction of increased arterial stiffness in patients with chronic inflammation: A 15-year followup study of 108 patients with rheumatoid arthritis. The Journal of Rheumatology, 38, 606-612. doi:10.3899/jrheum.100689
[18] Kampus, P., Muda, P., Kals, J., Ristimae, T., Fischer, K., Teesalu, R. and Zilmer, M. (2006) The relationship between inflammation and arterialstiffness in patients with essential hypertension. International Journal of Cardiology, 112, 46-51. doi:10.1016/j.ijcard.2005.08.026
[19] Simpson, K.A. and Singh, M.A. (2008) Effects of exercise on adiponectin: A systematic review. Obesity, 16, 241-256. doi:10.1038/oby.2007.53

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.